Alnylam Inc. (ALNY) Market Value to Book Value Ratio
Alnylam Pharmaceuticals (ALNY) bases its environmental policy on chemical waste recycling and laboratory energy efficiency. The historical relationship between market cap and book value demonstrates management's ability to maintain a market premium, with the current level sitting around 17.06. Risks are linked to high R&D costs and competition within the orphan drug sector, yet the strategy of expanding the RNA platform into the cardiology market opens new growth prospects.
Analytical breakdowns and data insights for company Alnylam Pharmaceuticals, Inc. (ALNY)
To identify fundamental stability, investors must track the market-to-book ratio, calculated as the ratio of the total market capitalization to the value of net assets. This chart allows for an assessment of the company's premium, which is critical for Alnylam Pharmaceuticals (ALNY) given its reliance on a narrow drug portfolio and the risks associated with late-stage clinical trial failures.